Cincinnati Doctors Say GLP-1 Drugs Ease Vascular Symptoms Beyond 2017-Era Weight Loss Use
Updated
Updated · WKRC TV Cincinnati · Aug 21
Cincinnati Doctors Say GLP-1 Drugs Ease Vascular Symptoms Beyond 2017-Era Weight Loss Use
3 articles · Updated · WKRC TV Cincinnati · Aug 21
Summary
Cincinnati vascular specialists said GLP-1 drugs are helping some patients beyond weight loss, easing leg heaviness, swelling, chronic pain and other inflammation-linked symptoms.
Dr. Andrew Hearn of the Vein Center of Cincinnati said improving metabolism can support vein and lymphatic health, while the drugs also curb cravings for processed foods that can worsen weight-related problems.
Patient Jonathan Ramon said he sought treatment after fatigue and heavy feet, had his varicose veins treated, then felt better after starting medication and cutting out foods such as bread and potato chips.
Ozempic, a GLP-1 introduced in 2017, and Zepbound, approved by the FDA in 2023, are already widely used for weight loss as researchers study broader uses for chronic conditions.